| Plasmacytoid dendritic cells: recent progress and open questions B Reizis, A Bunin, HS Ghosh, KL Lewis, V Sisirak Annual review of immunology 29 (1), 163-183, 2011 | 839 | 2011 |
| The role of dendritic cells in autoimmunity D Ganguly, S Haak, V Sisirak, B Reizis Nature Reviews Immunology 13 (8), 566-577, 2013 | 608 | 2013 |
| Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity V Sisirak, B Sally, V d’Agati, W Martinez-Ortiz, ZB Özçakar, J David, ... Cell 166 (1), 88-101, 2016 | 436 | 2016 |
| Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression V Sisirak, J Faget, M Gobert, N Goutagny, N Vey, I Treilleux, ... Cancer research 72 (20), 5188-5197, 2012 | 371 | 2012 |
| Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria V Flacher, M Bouschbacher, E Verronèse, C Massacrier, V Sisirak, ... The Journal of Immunology 177 (11), 7959-7967, 2006 | 332 | 2006 |
| Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus V Sisirak, D Ganguly, KL Lewis, C Couillault, L Tanaka, S Bolland, ... Journal of Experimental Medicine 211 (10), 1969-1976, 2014 | 256 | 2014 |
| Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer SI Labidi-Galy, V Sisirak, P Meeus, M Gobert, I Treilleux, A Bajard, ... Cancer research 71 (16), 5423-5434, 2011 | 252 | 2011 |
| Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment I Le Mercier, D Poujol, A Sanlaville, V Sisirak, M Gobert, I Durand, ... Cancer research 73 (15), 4629-4640, 2013 | 200 | 2013 |
| Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA L Serpas, RWY Chan, P Jiang, M Ni, K Sun, A Rashidfarrokhi, C Soni, ... Proceedings of the National Academy of Sciences 116 (2), 641-649, 2019 | 185 | 2019 |
| Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA C Soni, OA Perez, WN Voss, JN Pucella, L Serpas, J Mehl, KL Ching, ... Immunity 52 (6), 1022-1038. e7, 2020 | 154 | 2020 |
| Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells CM Sawai, V Sisirak, HS Ghosh, EZ Hou, M Ceribelli, LM Staudt, B Reizis Journal of Experimental Medicine 210 (11), 2151-2159, 2013 | 136 | 2013 |
| ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+ T cells by plasmacytoid dendritic cells J Faget, V Sisirak, JY Blay, C Caux, N Bendriss-Vermare, ... Oncoimmunology 2 (3), e23185, 2013 | 124 | 2013 |
| Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus J Hartl, L Serpas, Y Wang, A Rashidfarrokhi, OA Perez, B Sally, V Sisirak, ... Journal of Experimental Medicine 218 (5), e20201138, 2021 | 104 | 2021 |
| A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage C Dezutter-Dambuyant, I Durand, L Alberti, N Bendriss-Vermare, ... Oncoimmunology 5 (3), e1091146, 2016 | 103 | 2016 |
| Breast cancer‐derived transforming growth factor‐β and tumor necrosis factor‐α compromise interferon‐α production by tumor‐associated plasmacytoid dendritic cells V Sisirak, N Vey, N Goutagny, S Renaudineau, M Malfroy, S Thys, ... International journal of cancer 133 (3), 771-778, 2013 | 96 | 2013 |
| Systemic lupus erythematosus and systemic sclerosis: all roads lead to platelets M Scherlinger, V Guillotin, ME Truchetet, C Contin-Bordes, V Sisirak, ... Autoimmunity reviews 17 (6), 625-635, 2018 | 85 | 2018 |
| Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human and murine plasmacytoid dendritic cells A Bunin, V Sisirak, HS Ghosh, LT Grajkowska, ZE Hou, M Miron, C Yang, ... Immunity 43 (2), 277-288, 2015 | 67 | 2015 |
| Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+ regulatory T cells and are associated with poor prognosis in breast cancer patients V Sisirak, J Faget, N Vey, JY Blay, C Ménétrier-Caux, C Caux, ... Oncoimmunology 2 (1), e22338, 2013 | 65 | 2013 |
| Plasma DNA profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction RWY Chan, L Serpas, M Ni, S Volpi, LT Hiraki, LS Tam, A Rashidfarrokhi, ... The American Journal of Human Genetics 107 (5), 882-894, 2020 | 59 | 2020 |
| CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues V Sisirak, N Vey, B Vanbervliet, T Duhen, I Puisieux, B Homey, ... Blood, The Journal of the American Society of Hematology 118 (19), 5130-5140, 2011 | 58 | 2011 |
Jean-yves BlayProfesseur de Cancérologie Centre Leon Berard & University Claude Bernard Lyon IEmail confirmado em lyon.unicancer.fr